Evidence map›Paper›PMID 41562956›Full record

ArticleVision (Basel, Switzerland)2025

N-Acetyl-Aspartyl Glutamic Acid (NAAGA)-Based Eye Drops for Contact Lens Wearers with Dry Eye Symptoms and Discomfort.

Ioanna Misheva, Vesselin Daskalov, Dimitar Dzhelebov, Kalina Ilieva, Ralitsa Kermedchieva, Malina Topchiyska, Petar Yanev, Christina Grupcheva

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vision (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ioanna MishevaMedical Center for Eye Health Focus, 123 Bylgarska Morava Str., 1303 Sofia, Bulgaria.
Vesselin DaskalovSpecialized Ophthalmological Hospital for Active Treatment Pentagram, 109-111, Vranya Str., 1309 Sofia, Bulgaria.
Dimitar DzhelebovMedical Center Vereya, 4, Kenaly Str. Stara, 6000 Zagora, Bulgaria.
Kalina IlievaMedical Center for Eye Health Focus, 123 Bylgarska Morava Str., 1303 Sofia, Bulgaria.
Ralitsa KermedchievaSpecialized Ophthalmological Hospital for Active Treatment Pentagram, 109-111, Vranya Str., 1309 Sofia, Bulgaria.
Malina TopchiyskaMedical Center Oxycom Complex Izgrev, Bl. 28, Entr. A, Ground Floor, 8000 Burgas, Bulgaria.
Petar YanevAsmp Ob-Ip Glm Eood, 28 Han Presian Street, 4700 Smolyan, Bulgaria.
Christina GrupchevaInstitute for New Technologies in Ophthalmology (INTO), Seliolu1A, 9002 Varna, Bulgaria.ORCID 0000-0001-9965-1732

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the performance and safety of T2769 (Thealoz

Indexed as

anti-inflammatorybioprotectantcontact lensdry eye diseaselubricating eye drops

Identifiers

PMID41562956
PMCPMC12821722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.